Evidence map›Paper›PMID 32438726›Full record

ArticleJournal of clinical medicine2020

Clinical-Evolutionary Staging System of Primary Open-Angle Glaucoma Using Optical Coherence Tomography.

Alfonso Parra-Blesa, Alfredo Sanchez-Alberca, Jose Javier Garcia-Medina

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alfonso Parra-BlesaDepartment of Ophthalmology, Policlínica Baza, 18800 Baza (Granada), Spain.ORCID 0000-0003-1678-7488
Alfredo Sanchez-AlbercaDepartment of Statistics and Applied Maths, San Pablo CEU University, 28668 Madrid, Spain.ORCID 0000-0002-8950-2044
Jose Javier Garcia-MedinaDepartment of Ophthalmology, General University Hospital Morales Meseguer, 30100 Murcia, Spain.ORCID 0000-0002-6245-7271
Universidad San Pablo CEU · ESHospital General Universitario Morales Meseguer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary open-angle glaucoma (POAG) is considered one of the main causes of blindness. Detection of POAG at early stages and classification into evolutionary stages is crucial to blindness prevention.

methods1001 patients were enrolled, of whom 766 were healthy subjects and 235 were ocular hypertensive or glaucomatous patients in different stages of the disease. Spectral domain optical coherence tomography (SD-OCT) was used to determine Bruch's membrane opening-minimum rim width (BMO-MRW) and the thicknesses of peripapillary retinal nerve fibre layer (RNFL) rings with diameters of 3.0, 4.1 and 4.7 mm centred on the optic nerve. The BMO-MRW rim and RNFL rings were divided into seven sectors (G-T-TS-TI-N-NS-NI). The k-means algorithm and linear discriminant analysis were used to classify patients into disease stages.

resultsWe defined four glaucoma stages and provided a new model for classifying eyes into these stages, with an overall accuracy greater than 92% (88% when including healthy eyes). An online application was also implemented to predict the probability of glaucoma stage for any given eye.

conclusionsWe propose a new objective algorithm for classifying POAG into clinical-evolutionary stages using SD-OCT.

Indexed as

evolutionary stagesprimary open-angle glaucomaretinal diseaseretinal imagingspectral domain-optical coherence tomography

Identifiers

PMID32438726
PMCPMC7290744
OpenAlexW3027983432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.